Asp50Glu mutation in MurA results in fosfomycin resistance in Enterococcus faecium

Ling Xin1, Zetao Hu2, Renru Han1

  • 1Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China; Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, Shanghai, China.

Abstract

Insights

A novel Asp50Glu mutation in the MurA protein of Enterococcus faecium confers significant fosfomycin resistance. This discovery deepens our understanding of antibiotic resistance mechanisms and aids in developing new MurA-targeted antibiotics.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Enterococcus faecium is a significant cause of hospital-acquired infections.
  • Fosfomycin resistance in E. faecium can arise from plasmid-encoded genes or chromosomal mutations.
  • Mutations in the MurA protein represent a recently identified mechanism of fosfomycin resistance.

Purpose of the Study:

  • To investigate a novel Asp50Glu mutation in the MurA protein of a fosfomycin-resistant Enterococcus faecium clinical isolate.
  • To elucidate the role and mechanism of the Asp50Glu MurA mutant in conferring fosfomycin resistance.
  • To characterize the enzymatic properties of the mutant MurA protein.

Main Methods:

  • Gene cloning, protein expression, and purification of wild-type and mutant MurA.
  • Steady-state kinetic assays and fosfomycin inhibition studies.
  • Next-generation sequencing (NGS) for comprehensive analysis.

Main Results:

  • The Asp50Glu MurA mutant was identified in a fosfomycin-resistant E. faecium isolate (MIC = 512 mg/L).
  • This mutation conferred a 4-fold increase in fosfomycin minimum inhibitory concentration (MIC).
  • Asp50Glu MurA exhibited increased substrate affinity and resistance to fosfomycin inhibition (up to 100 mg/L).

Conclusions:

  • The Asp50Glu MurA mutation is a novel mechanism contributing to fosfomycin resistance in E. faecium.
  • Understanding this mechanism provides new insights into antibiotic resistance.
  • This research facilitates the development of new antibiotics targeting the MurA enzyme.